Melanoma, Secondary cancers, Skin cancer
Results
Phase 3
This trial looked at a drug called pembrolizumab for melanoma that couldn’t be removed with surgery or that had spread to another part of the body. The trial was open to people with advanced melanoma who hadn’t had a drug called ipilimumab.
Recruitment start: 4 September 2013
Recruitment end: 31 January 2014
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Experimental Cancer Medicine Centre (ECMC)
Merck Sharp & Dohme Ltd
Last reviewed: 04 Aug 2016
CRUK internal database number: 11476
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
